Naming of Biologics: We want to hear from you!

We'd like to hear your thoughts about the naming of biologic drugs including biosimilars. This questionnaire consists of 5 questions.

Access the Consultation and Questionnaire link below:
lnkd.in/dZFZXc9

Your responses before February 9th, to this consultation questionnaire will help to inform the development of Health Canada's naming policy to distinguish among biologic drugs that share the same non-proprietary name.

Thanks!
Alice